Cibinetide dampens innate immune cell functions thus ameliorating the course of experimental colitis

DSpace/Manakin Repository

Cibinetide dampens innate immune cell functions thus ameliorating the course of experimental colitis

Citable link to this page

 

 
Title: Cibinetide dampens innate immune cell functions thus ameliorating the course of experimental colitis
Author: Nairz, Manfred; Haschka, David; Dichtl, Stefanie; Sonnweber, Thomas; Schroll, Andrea; Aßhoff, Malte; Mindur, John E.; Moser, Patrizia L.; Wolf, Dominik; Swirski, Filip K.; Theurl, Igor; Cerami, Anthony; Brines, Michael; Weiss, Günter

Note: Order does not necessarily reflect citation order of authors.

Citation: Nairz, M., D. Haschka, S. Dichtl, T. Sonnweber, A. Schroll, M. Aßhoff, J. E. Mindur, et al. 2017. “Cibinetide dampens innate immune cell functions thus ameliorating the course of experimental colitis.” Scientific Reports 7 (1): 13012. doi:10.1038/s41598-017-13046-3. http://dx.doi.org/10.1038/s41598-017-13046-3.
Full Text & Related Files:
Abstract: Two distinct forms of the erythropoietin receptor (EPOR) mediate the cellular responses to erythropoietin (EPO) in different tissues. EPOR homodimers signal to promote the maturation of erythroid progenitor cells. In other cell types, including immune cells, EPOR and the ß-common receptor (CD131) form heteromers (the innate repair receptor; IRR), and exert tissue protective effects. We used dextran sulphate sodium (DSS) to induce colitis in C57BL/6 N mice. Once colitis was established, mice were treated with solvent, EPO or the selective IRR agonist cibinetide. We found that both cibinetide and EPO ameliorated the clinical course of experimental colitis in mice, resulting in improved weight gain and survival. Correspondingly, DSS-exposed mice treated with cibinetide or EPO displayed preserved tissue integrity due to reduced infiltration of myeloid cells and diminished production of pro-inflammatory disease mediators including cytokines, chemokines and nitric oxide synthase-2. Experiments using LPS-activated primary macrophages revealed that the anti-inflammatory effects of cibinetide were dependent on CD131 and JAK2 functionality and were mediated via inhibition of NF-κB subunit p65 activity. Cibinetide activation of the IRR exerts potent anti-inflammatory effects, especially within the myeloid population, reduces disease activity and mortality in mice. Cibinetide thus holds promise as novel disease-modifying therapeutic of inflammatory bowel disease.
Published Version: doi:10.1038/s41598-017-13046-3
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638901/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:34492453
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters